Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 39.3138.0544.5313.9839.84

What is the latest Price to Cash Earnings (PCE) ratio of MEDICAMEN BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of MEDICAMEN BIOTECH is 39.31 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202339.31
Mar202238.05
Mar202144.53
Mar202013.98
Mar201939.84

How is Price to Cash Earnings (PCE) of MEDICAMEN BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 39.31
3.31
Mar2022 38.05
-14.55
Mar2021 44.53
218.53
Mar2020 13.98
-64.91
Mar2019 39.84 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹735.5 Cr 33.4% 51% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

33.4%

51%

-17%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses